Monday, November 25, 2024
Home Authors Posts by Editor / Curator

Editor / Curator

928 POSTS 0 COMMENTS
America BriVision, Biotech Stock Review
Incubator

Adding American BriVision (ABVC) $2.00 to Watch List.

Editor / Curator -
Biotech News

Athersys (ATHX) Overview and Due Diligence links (Reddit)

Editor / Curator -
Internet Stock Review
Stand Down.

Immunomedics (IMMU) up 100% Today or $2 Billion in Value &...

Editor / Curator -
Biotech Stock Review, Novellus, Citius
Biotech News

Citius (CTXR) and Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS)...

Editor / Curator -
Superbug News - CoronaVirus Watch List

New Report: Citius (CTXR) Trades 13 Million Shares on CoronaVirus and...

Editor / Curator -
OMNIQ
Cybersecurity

OMNIQ (OMQS) Corp. Acquires Eyepax Parking Assets.

Editor / Curator -
All News

‘Early Detection, Early Response.’ How Smallpox Which Killed 300 Million, Was...

Editor / Curator -
Biotech Stock Review
Superbug News - CoronaVirus Watch List

Regular Old Flu, Kills 290,000 to 650,000 a Year.

Editor / Curator -
Superbug News - CoronaVirus Watch List

Let’s be ‘Corona Clever’ and Catch one Before the POP. Athersys...

Editor / Curator -
video
Superbug News - CoronaVirus Watch List

CoronaVirus Story of the Day. “How Lucky Can One Guy Be.”

Editor / Curator -
1...697071...93Page 70 of 93

Latest article

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

All News Editor / Curator -
Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.